KOREA WHO
-
-
-
Chairman and CEO of Jetema
Kim Jae-young
Korea’s Filler Pioneer Boosts Jetema Toxin Push
-
Last Updated on Nov 24, 2025
-
Chairman and CEO of Jetema
Life Summary
Kim Jae-young is the CEO of Jetema.
He was born on August 5, 1968.
He graduated from the College of Pharmacy at Kyung Hee University and earned a Ph.D. in biomedical engineering at Kyung Hee University.
As part of the first generation in Korea’s filler and biopharmaceutical industry, he co-founded HLVS (Humedics), a domestic filler manufacturer.
He later joined Jetema, a developer and producer of hyaluronic acid fillers and botulinum toxin products, and went on to lead the company.
He led business expansion and facility investment, including the acquisition of Human Medical and the establishment of a dedicated hyaluronic acid filler plant.
He has a strong interest in bone growth factors and is focusing on diversifying the business portfolio and expanding global operations.
#Jetema #KimJaeyoung #biomedicalengineering #hyaluronicacid #fillerindustry #botulinumtoxin #biopharmaceuticals #M&A #globalexpansion #Kbio
He was born on August 5, 1968.
He graduated from the College of Pharmacy at Kyung Hee University and earned a Ph.D. in biomedical engineering at Kyung Hee University.
As part of the first generation in Korea’s filler and biopharmaceutical industry, he co-founded HLVS (Humedics), a domestic filler manufacturer.
He later joined Jetema, a developer and producer of hyaluronic acid fillers and botulinum toxin products, and went on to lead the company.
He led business expansion and facility investment, including the acquisition of Human Medical and the establishment of a dedicated hyaluronic acid filler plant.
He has a strong interest in bone growth factors and is focusing on diversifying the business portfolio and expanding global operations.
#Jetema #KimJaeyoung #biomedicalengineering #hyaluronicacid #fillerindustry #botulinumtoxin #biopharmaceuticals #M&A #globalexpansion #Kbio